Method for modulating light penetration depth in tissue and diagnostic applications using same

• US 7,043,287 B1
• Filed: 10/15/1999
• Issued: 05/09/2006
• Est. Priority Date: 05/18/1998
• Status: Expired due to Term

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Khalil, Omar S., Jeng, Tzyy-Wen, Hanna, Charles F., Kantor, Stanislaw, Wu, Xiaomao, Yeh, Shu-Jen
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US09/419,461
• Time in Patent Office: 2,398 Days
• Field of Search: 600310-311, 600/316, 600322-324, 600/326, 600/328, 600/334, 600/339, 356 39- 41
• US Class Current: 600/310
• CPC Class Codes: A61B 2562/0242 for varying or adjusting the optical path length in the tissue
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes

Abstract

Devices and methods for non-invasively measuring at least one parameter of a sample, such as the presence of a disease condition, progression of a disease state, presence of an analyte, or concentration of an analyte, in a biological sample, such as, for example, a body part. In these devices and methods, temperature is controlled and is varied between preset boundaries. The methods and devices measure light that is reflected, scattered, absorbed, or emitted by the sample from an average sampling depth, d_av, that is confined within a region in the sample wherein temperature is controlled. According to the method of this invention, the sampling depth d_av, in human tissue is modified by changing the temperature of the tissue. The sampling depth increases as the temperature is lowered below the body core temperature and decreases when the temperature is raised within or above the body core temperature. Changing the temperature at the measurement site changes the light penetration depth in tissue and hence d_av. Change in light penetration in tissue as a function of temperature can be used to estimate the presence of a disease condition, progression of a disease state, presence of an analyte, or concentration of an analyte in a biological sample. According to the method of this invention, an optical measurement is performed on a biological sample at a first temperature. Then, when the optical measurement is repeated at a second temperature, light will penetrate into the biological sample to a depth that is different from the depth to which light penetrates at the first temperature by from about 5% to about 20%.

Claims

1. A method of measuring at least one optical parameter of intact human tissue, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light penetration depth, said method comprising the steps of:

(a) setting the temperature of said intact human tissue to a first temperature and allowing said intact human tissue to equilibrate at said first temperature before optical data are collected at said first temperature, said first temperature being within the range of from about 0°

C. to about 45°

C.;

(b) performing an optical measurement on said intact human tissue at said first temperature, wherein said optical measurement is a spatially resolved diffuse reflectance measurement;

(c) determining at least one optical parameter of said intact human tissue from said spatially resolved diffuse reflectance measurement at said first temperature, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light penetration depth, said first temperature corresponding to a first depth in said intact human tissue;

(d) changing said first temperature of said intact human tissue to at least a second temperature and allowing said intact human tissue to equilibrate at at least said second temperature before optical data are collected at said at least said second temperature, said at least second temperature being within the range of from about 0°

C. to about 45°

C.;

(e) performing said an optical measurement on said intact human tissue at said at least second temperature, wherein said optical measurement is a spatially resolved diffuse reflectance measurement;

(f) determining said at least one optical parameter of said intact human tissue from said spatially resolved diffuse reflectance measurement at at least a second temperature, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light penetration depth, said at least second temperature corresponding to a second depth in said intact human tissue; and

(g) determining said at least one parameter of said intact human tissue from the functional relationship of said at least one optical parameter on depth in said intact human tissue, wherein said optical measurements in step (b) and step (e) are carried out by transmitting light into a region of said intact human tissue at a light introduction site and collecting light re-emitted from said region of intact human tissue at a light collection site, wherein the distance between any light introduction site and any light collection site is less than three millimeters.

2. The method of claim 1, wherein said change in temperature of said intact human tissue results in a change in penetration depth of light in said intact human tissue.

3. The method of claim 1, wherein said first temperature and said at least second temperature are within a range from about 15°

C. to about 45°

C.

4. The method of claim 1, wherein said optical measurement is performed using light at at least one wavelength in a range from about 400 nm to about 2500 nm.

5. The method of claim 1, wherein said optical measurement is performed using light at at least one wavelength in a range from about 600 nm to about 1300 nm.

6. The method of claim 1, wherein said at least one parameter of said intact human tissue is the concentration of an analyte.

7. The method of claim 6, wherein said analyte is glucose, hemoglobin, or water.

8. The method of claim 1, wherein said intact human tissue is intact human skin, esophagus tissue, intestine tissue, or cervical tissue.

9. The method of claim 1, wherein said at least one parameter of said intact human tissue is a parameter indicating a disease state.

10. The method of claim 9, wherein said disease state is diabetic state, vascular disease state, dermatological disease state, or neoplasmic disease state.

11. A method of measuring at least one optical parameter of intact human tissue having a plurality of layers, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light penetration depth, said method comprising the steps of:

(a) setting the temperature of said intact human tissue to a first temperature and allowing said intact human tissue to equilibrate at said first temperature before optical data are collected at said first temperature, said first temperature being within the range of from about 0°

C. to about 45°

C.;

(b) performing an optical measurement on said intact human tissue at said first temperature, wherein said optical measurement is a spatially resolved diffuse reflectance measurement;

(c) determining at least one optical parameter of a first layer of said intact human tissue from said spatially resolved diffuse reflectance measurement, said first layer being located at a first depth of said intact human tissue, said first temperature corresponding to a first depth of said intact human tissue, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light penetration depth;

(d) changing said first temperature of said intact human tissue to at least a second temperature and allowing said intact human tissue to equilibrate at said at least second temperature before optical data are collected at said at least second temperature, said at least second temperature being within the range of from about 0°

C. to about 45°

C.;

(e) performing said an optical measurement on said intact human tissue at said at least second temperature;

(f) determining said at least one optical parameter at at least a second layer of said intact human tissue from said spatially resolved diffuse reflectance measurement, said at least second layer being located at at least a second depth of said intact human tissue, said at least second temperature corresponding to said second depth of said intact human tissue, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light-penetration depth; and

(g) determining said at least one parameter of said intact human tissue from the functional dependence of said at least one optical parameter on depth in said intact human tissue, wherein said optical measurements in step (b) and step (e) are carried out by transmitting light into a region of said intact human tissue at a light introduction site and collecting light re-emitted from said region of intact human tissue at a light collection site, wherein the distance between any light introduction site and any light collection site is less than three millimeters.

12. The method of claim 11, wherein said change in temperature of said intact human tissue results in a change in penetration depth of light in said intact human tissue.

13. The method of claim 11, wherein said first temperature and said at least second temperature are within a range from about 10°

C. to about 42°

C.

14. The method of claim 11, wherein said optical measurement is performed using light at at least one wavelength in a range from about 400 nm to about 2500 nm.

15. The method of claim 11, wherein said optical measurement is performed using light at at least one wavelength in a range from about 600 nm to about 1300 nm.

16. The method of claim 11, wherein said at least one parameter of said intact human tissue is the concentration of an analyte.

17. The method of claim 16, wherein said analyte is glucose, hemoglobin, or water.

18. The method of claim 11, wherein said intact human tissue is intact human skin, esophagus tissue, intestine tissue, or cervical tissue.

19. The method of claim 11, wherein said at least one parameter of said intact human tissue is a parameter indicating a disease state.

20. The method of claim 19, wherein said disease state is diabetic state, vascular disease state, dermatological disease state, or neoplasmic disease state.

21. An apparatus for measuring at least one optical parameter of intact human tissue, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light penetration depth, said apparatus comprising:

(a) a source of light for irradiating a region of said intact human tissue with light at at least one light introduction site;

(b) a means for collecting light re-emitted from said region of said intact human tissue at at least one light collection site, wherein the distance between any light introduction site and any light collection site is less than three millimeters;

(c) a means for changing the temperature of said intact human tissue to a temperature ranging from about 0°

C. to about 45°

C. so that radiation penetrates to a specified depth in said intact human tissue;

(d) a detector for measuring the intensity of the collected re-emitted light at a plurality of temperatures, wherein the measured intensities correspond to light re-emitted from different depths of said intact human tissue, wherein said intensity of said collected re-emitted light is used to determine spatially resolved diffuse reflectance of said intact human tissue; and

(e) a means for calculating at least one parameter of said intact human tissue from said spatially resolved diffuse reflectance and the dependence of at least one optical parameter on depth in said intact human tissue, wherein said at least one optical parameter is selected from the group consisting of absorption coefficient, scattering coefficient, mean free path, effective attenuation coefficient, and light penetration depth.

22. The apparatus of claim 21, wherein said change in temperature of said intact human tissue results in a change in penetration depth of light in said intact human tissue.

23. The apparatus of claim 21, wherein said light used to irradiate said intact human tissue has at least one wavelength ranging from about 400 nm to about 2500 nm.

24. The apparatus of claim 21, wherein said light used to irradiate said intact human tissue has at least one wavelength ranging from about 600 nm to about 1300 nm.

25. The apparatus of claim 21, wherein said at least one parameter of said intact human tissue is the concentration of an analyte.

26. The method of claim 25, wherein said analyte is selected from the group consisting of glucose, hemoglobin, and water.

27. The apparatus of claim 21, wherein said intact human tissue is selected from the group consisting of intact human skin, esophageal tissue, intestine tissue, or cervical tissue.

28. The apparatus of claim 21, wherein said at least one parameter of said intact human tissue is an indicator of a disease state.

29. The apparatus of claim 21, wherein said at least one optical parameter is indicative of a disease state, wherein said disease state is selected from the group consisting of diabetic state, vascular disease state, dermatological disease state, and neoplasmic disease state.

30. The apparatus of claim 21, wherein said irradiation means and said temperature changing means are included in an endoscope.